Femara 2.5mg Tablet contains Letrozole, a potent aromatase inhibitor used primarily for the treatment of breast cancer in postmenopausal women.

 It works by reducing estrogen production in the body, which helps slow or stop the growth of hormone-dependent breast cancer cells.

Femara is also sometimes used for fertility treatment in women with ovulation problems, under a doctor’s supervision. 

This medicine helps control cancer progression and improves long-term survival outcomes.

Key Benefits:

Helps treat hormone-dependent breast cancer in postmenopausal women

Reduces estrogen levels to stop cancer cell growth

Lowers risk of cancer recurrence after surgery or therapy

Sometimes used to stimulate ovulation in infertility cases (doctor prescribed)

Improves overall survival and treatment success rate

Uses:

Treatment of breast cancer in postmenopausal women

Prevention of cancer recurrence after surgery or radiation

Off-label use for ovulation induction (under doctor supervision)

Dosage:

The usual recommended dose is one tablet (2.5mg) once daily, with or without food.

Take at the same time each day for best results.

Continue for as long as your doctor prescribes — typically several months or years.

Do not stop or change dosage without consulting your doctor.

Safety Information:

Regular monitoring of hormone levels and bone health is advised.

Not recommended for premenopausal women, pregnancy, or breastfeeding.

May cause fatigue, dizziness, or joint pain — avoid driving if affected.

Store in a cool, dry place below 25°C, away from moisture.

Keep out of reach of children.